TipRanks
Go Ultimate55% OFF

Mani, Inc. (7730) AI Stock Analysis

0 Followers
JP:7730

Mani, Inc.

(TSE/TYO:7730)

Select Model
Rating:76Outperform
Price Target:JPY 1,707.00â–²(10.70% Upside)
Action:reiterated
Date:10/16/26

Mani Inc.'s strong overall score is primarily driven by its exceptional fundamental health, characterized by a fortress balance sheet and highly profitable operations. A fair valuation and solid dividend yield bolster its appeal. The score is modestly tempered by mixed technical indicators, as recent short-term price recoveries face long-term moving average resistance alongside overbought stochastic conditions.

Positive Factors
Steady Revenue GrowthRevenue has grown steadily across several years and re-accelerated in the latest annual period. That trajectory indicates expanding demand for Mani’s dental and surgical products, supporting continued scale benefits and providing a durable base for investment, market development, and earnings growth over the next several quarters.
Negative Factors
Volatile Free Cash FlowFree cash flow has not tracked profits consistently, falling close to zero relative to net income in 2024 and 2025 before recovering in 2026. Swings in investment spending or working capital can reduce cash-flow predictability and complicate funding and capital-allocation decisions.

Mani, Inc. (7730) vs. iShares MSCI Japan ETF (EWJ)

-10%0%10%20%30%40%JP:7730+7.44%EWJ+10.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 151.69B
Dividend Yield
2.79%
Average Volume (3M)
337.95K
Price to Earnings (P/E)
20.9
Beta (1Y)
1.13
Revenue Growth
10.18%
EPS Growth
55.86%
Country
Japan
Employees
4,140
Sector
General
Sector Strength
55
Industry
Medical - Instruments & Supplies

Mani, Inc. Business Overview & Revenue Model

Company Description

Mani, Inc. engages in the manufacture and supply of surgical and dental instruments in Japan, Asia, Europe, North America, and internationally. The company operates through three segments: Surgical Products, Eyeless Needle Products, and Dental Produc...

How the Company Makes Money

Mani, Inc. makes money mainly by selling its medical-device products to healthcare markets through distribution channels. Key revenue streams are (1) dental-related products—particularly endodontic and other dental instruments and consumables that ar...

Mani, Inc. Financial Statement Overview

Summary

The company exhibits exceptional financial health, highlighted by an immaculate, nearly debt-free balance sheet, consistent top-line growth, and robust free cash flow generation. High margins and a strong recovery in net income further underscore its operational resilience.

Income Statement

88Very Positive

Balance Sheet

96Very Positive

Cash Flow

84Very Positive
Financial statement breakdown
BreakdownTTMAug 2026Aug 2025Aug 2024Aug 2023Aug 2022
Income Statement
Total Revenue33.02B33.02B29.97B28.51B24.49B20.42B
Gross Profit21.98B21.98B19.32B17.90B15.42B12.57B
EBITDA12.92B12.38B9.56B10.70B9.94B9.17B
Net Income7.24B7.24B4.64B6.29B5.95B5.29B
Balance Sheet
Total Assets65.09B65.09B58.19B57.33B55.11B50.18B
Cash, Cash Equivalents and Short-Term Investments26.50B26.50B18.73B21.66B25.43B22.73B
Total Debt81.00M81.00M76.00M83.00M58.00M117.00M
Total Liabilities6.10B6.10B4.63B5.00B5.28B4.76B
Stockholders Equity58.99B58.99B53.56B52.33B49.83B45.41B
Cash Flow
Free Cash Flow010.73B612.00M397.00M4.52B4.76B
Operating Cash Flow011.85B7.03B7.82B8.03B6.57B
Investing Cash Flow0-860.00M-7.17B-6.65B-4.02B-2.19B
Financing Cash Flow0-4.00B-3.90B-3.70B-3.25B-2.44B

Mani, Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price1542.00

Price Trends

50DMA1501.28Negative
100DMA1557.42Negative
200DMA1575.54Negative

Market Momentum

MACD0.43Positive
RSI41.10Neutral
STOCH24.92Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7730, the sentiment is Negative. The current price of 1542.00 is above the 20-day moving average (MA) of 1507.40, above the 50-day MA of 1501.28, and below the 200-day MA of 1575.54, indicating a bearish trend. The MACD of 0.43 indicates Positive momentum. The RSI at 41.10 is Neutral, neither overbought nor oversold. The STOCH value of 24.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7730.

Mani, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:7730 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:7730JP:773076OutperformJPY 146.79B20.95―2.79%10.18%55.86%
JP:7747JP:774772OutperformJPY 936.06B32.2719.88%1.37%21.16%156.97%
JP:7979JP:797966NeutralJPY 78.82B12.95―2.76%6.53%52.32%
JP:7716JP:771660NeutralJPY 243.75B103.361.89%2.14%14.87%-55.19%
JP:7733JP:773359NeutralJPY 1.91T25.9910.21%3.47%7.80%-27.73%
JP:8086JP:808656NeutralJPY 241.01B16.835.35%2.28%2.68%144.20%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-25%0%25%50%JP:7730JP:7747JP:7716JP:8086JP:7733JP:7979Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7730 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7730Mani, Inc.1542.00122.338.62%
JP:7747Asahi Intecc Co 3890.001517.6363.97%
JP:7716Nakanishi 1442.00473.5048.89%
JP:8086Nipro Corporation1447.502.920.20%
JP:7733Olympus Corp1845.5037.952.10%
JP:7979Shofu Inc.2162.00384.8521.66%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 16, 2026